Yoshiko Urata
Akashi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Journal: International journal of clinical oncology
Published: August 03, 2022
Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR).
Journal: Translational lung cancer research
Published: March 25, 2021
The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients.
Journal: Respiratory investigation
Published: September 04, 2019
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.
Journal: BMC cancer
Published: July 24, 2019
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 14, 2018
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 09, 2018
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
Journal: BMC cancer
Published: April 05, 2018
Immune-related Colitis Induced by the Long-term Use of Nivolumab in a Patient with Non-small Cell Lung Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: December 28, 2017
The safety and efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel in the treatment of non-small cell lung cancer patients with interstitial lung disease.
Journal: Japanese journal of clinical oncology
Published: June 21, 2017
Reply to C.-H. Chang et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 07, 2017
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 30, 2016
I. What is the Standard Treatment of EGFR-TKIs? Did EGFR-TKIs Improve Treatment for Non-Small Cell Lung Cancer?
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 11, 2015
Last Updated: 09/26/2026